These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16287452)

  • 1. An epidemiological survey of overactive bladder symptoms in Japan.
    Homma Y; Yamaguchi O; Hayashi K;
    BJU Int; 2005 Dec; 96(9):1314-8. PubMed ID: 16287452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic survey of lower urinary tract symptoms in Japan.
    Homma Y; Yamaguchi O; Hayashi K;
    Urology; 2006 Sep; 68(3):560-4. PubMed ID: 16979726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
    Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
    Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey.
    Herschorn S; Gajewski J; Schulz J; Corcos J
    BJU Int; 2008 Jan; 101(1):52-8. PubMed ID: 17908260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.
    Wang Y; Xu K; Hu H; Zhang X; Wang X; Na Y; Kang X
    Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the overactive bladder syndrome by applying the International Continence Society definition.
    Temml C; Heidler S; Ponholzer A; Madersbacher S
    Eur Urol; 2005 Oct; 48(4):622-7. PubMed ID: 15964133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the effect of overactive bladder symptoms on woman's quality of life during and after first pregnancy?
    Van Brummen HJ; Bruinse HW; Van de Pol G; Heintz AP; Van der Vaart CH
    BJU Int; 2006 Feb; 97(2):296-300. PubMed ID: 16430633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of overactive bladder and nocturnal enuresis in Japanese early adolescents: a questionnaire survey.
    Kajiwara M; Inoue K; Mutaguchi K; Usui T
    Hinyokika Kiyo; 2006 Feb; 52(2):107-11. PubMed ID: 16541763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower urinary tract symptoms: lack of change in prevalence and help-seeking behaviour in two population-based surveys of women in 1991 and 2007.
    Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
    BJU Int; 2009 Oct; 104(7):954-9. PubMed ID: 19388983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of urinary incontinence and overactive bladder syndrome on health-related quality of life of working middle-aged patients and institutionalized elderly patients].
    Martínez Agulló E; Ruíz Cerdá JL; Gómez Pérez L; Rebollo P; Pérez M; Chaves J
    Actas Urol Esp; 2010 Mar; 34(3):242-50. PubMed ID: 20416241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women.
    Teleman PM; Lidfeldt J; Nerbrand C; Samsioe G; Mattiasson A;
    BJOG; 2004 Jun; 111(6):600-4. PubMed ID: 15198789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of overactive bladder and incontinence in Canada.
    Corcos J; Schick E
    Can J Urol; 2004 Jun; 11(3):2278-84. PubMed ID: 15287994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
    Garely AD; Lucente V; Vapnek J; Smith N
    Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Cardozo L
    BJU Int; 2006 Jan; 97(1):96-100. PubMed ID: 16336336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bothersome lower urinary tract symptoms 1 year after first delivery: prevalence and the effect of childbirth.
    van Brummen HJ; Bruinse HW; van de Pol G; Heintz AP; van der Vaart CH
    BJU Int; 2006 Jul; 98(1):89-95. PubMed ID: 16831150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.